In vitro diagnostics will
remain the number one
device area in 2022,
with sales of $70.8B –
more than 13% of the
industry’s total sales.
Roche is the leading
company in this segment, with its 2022
test sales forecast to
Merger mania leaves Medtronic
Consolidation within the medtech
industry is winding down, with
settled, Medtronic has emerged
as the largest company by sales of
its medtech revenues are forecast
There are still a few sector-chang-ing deals in the pipeline. Most notable is Abbott’s pending purchase
could help bump Abbott up the
company rankings from seventh
position overall to third.
Ten-year approvals high
has had an outstanding year, increas-ing;the;number;of;first-time;PMAs
That said, the pace seems to have
slowed slightly since. The preview
found that up to the end of August
As if to compensate, over the same
over the same point last year.
Overall the device industry is growing reasonably rapidly, and
the calming of the M&A
scene is no bad thing.
Already the sector is seeing a
resurgence of smaller tuck-in deals
source of disruptive new technologies, depend.
forecast to grow more slowly than
prescription drug market, with a
en…and Medtronic remains top in
•;Johnson;&;Johnson;retains;lead-ing position in the orthopedics
tinues domination of sector with
the cardiology market; sales fore-
Worldwide Medtech Sales
Forecast to Reach $529.8B by
2022; IVD Remains Number
One in 2022.
The report’s consensus forecasts
try’s total sales. Cardiology takes
the second spot, with annual sales
fastest-growing device area, with a
2022.;See figures 1 & 2, page 36.